Going with the Flow: From Circulating Tumor Cells to DNA

被引:106
作者
Bidard, Francois-Clement [1 ,2 ]
Weigelt, Britta [1 ]
Reis-Filho, Jorge S. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA
[2] Inst Curie, Dept Med Oncol, F-75005 Paris, France
关键词
BREAST-CANCER PATIENTS; GENETIC-HETEROGENEITY; MUTATIONAL EVOLUTION; ACQUIRED-RESISTANCE; COLORECTAL-CANCER; PERIPHERAL-BLOOD; METASTATIC SITES; PROSTATE-CANCER; RARE MUTATIONS; PLASMA;
D O I
10.1126/scitranslmed.3006305
中图分类号
Q2 [细胞生物学];
学科分类号
071013 [干细胞生物学];
摘要
Molecular analyses of circulating tumor DNA (ctDNA) in plasma from cancer patients have the potential to deliver minimally invasive diagnostic and disease-monitoring biomarkers. Drawing from experience gained through the translation of circulating-tumor cell detection to clinical tests, we discuss ctDNA as a source of tumor material for biomarker development.
引用
收藏
页数:7
相关论文
共 57 条
[1]
Circulating Tumor Cells: Liquid Biopsy of Cancer [J].
Alix-Panabieres, Catherine ;
Pantel, Klaus .
CLINICAL CHEMISTRY, 2013, 59 (01) :110-118
[2]
The Implications of Clonal Genome Evolution for Cancer Medicine [J].
Aparicio, Samuel ;
Caldas, Carlos .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (09) :842-851
[3]
Tumour heterogeneity in the clinic [J].
Bedard, Philippe L. ;
Hansen, Aaron R. ;
Ratain, Mark J. ;
Siu, Lillian L. .
NATURE, 2013, 501 (7467) :355-364
[4]
Mutation-based detection and monitoring of cell-free tumor DNA in peripheral blood of cancer patients [J].
Benesova, L. ;
Belsanova, B. ;
Suchanek, S. ;
Kopeckova, M. ;
Minarikova, P. ;
Lipska, L. ;
Levy, M. ;
Visokai, V. ;
Zavoral, M. ;
Minarik, M. .
ANALYTICAL BIOCHEMISTRY, 2013, 433 (02) :227-234
[5]
Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma [J].
Bidard, Francois-Clement ;
Madic, Jordan ;
Mariani, Pascale ;
Piperno-Neumann, Sophie ;
Rampanou, Aurore ;
Servois, Vincent ;
Cassoux, Nathalie ;
Desjardins, Laurence ;
Milder, Maud ;
Vaucher, Isabelle ;
Pierga, Jean-Yves ;
Lebofsky, Ronald ;
Stern, Marc-Henri ;
Lantz, Olivier .
INTERNATIONAL JOURNAL OF CANCER, 2014, 134 (05) :1207-1213
[6]
Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials [J].
Bidard, Francois-Clement ;
Fehm, Tanja ;
Ignatiadis, Michail ;
Smerage, Jeffrey B. ;
Alix-Panabieres, Catherine ;
Janni, Wolfgang ;
Messina, Carlo ;
Paoletti, Costanza ;
Mueller, Volkmar ;
Hayes, Daniel F. ;
Piccart, Martine ;
Pierga, Jean-Yves .
CANCER AND METASTASIS REVIEWS, 2013, 32 (1-2) :179-188
[7]
Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer [J].
Board, Ruth E. ;
Wardley, Andrew M. ;
Dixon, J. Michael ;
Armstrong, Anne C. ;
Howell, Sacha ;
Renshaw, Lorna ;
Donald, Emma ;
Greystoke, Alastair ;
Ranson, Malcolm ;
Hughes, Andrew ;
Dive, Caroline .
BREAST CANCER RESEARCH AND TREATMENT, 2010, 120 (02) :461-467
[8]
The causes and consequences of genetic heterogeneity in cancer evolution [J].
Burrell, Rebecca A. ;
McGranahan, Nicholas ;
Bartek, Jiri ;
Swanton, Charles .
NATURE, 2013, 501 (7467) :338-345
[9]
Cancer Genome Scanning in Plasma: Detection of Tumor-Associated Copy Number Aberrations, Single-Nucleotide Variants, and Tumoral Heterogeneity by Massively Parallel Sequencing [J].
Chan, K. C. Allen ;
Jiang, Peiyong ;
Zheng, Yama W. L. ;
Liao, Gary J. W. ;
Sun, Hao ;
Wong, John ;
Siu, Shing Shun N. ;
Chan, Wing C. ;
Chan, Stephen L. ;
Chan, Anthony T. C. ;
Lai, Paul B. S. ;
Chiu, Rossa W. K. ;
Lo, Y. M. D. .
CLINICAL CHEMISTRY, 2013, 59 (01) :211-224
[10]
Analysis of Cancer Mutation Signatures in Blood by a Novel Ultra-Sensitive Assay: Monitoring of Therapy or Recurrence in Non-Metastatic Breast Cancer [J].
Chen, Zhenbin ;
Feng, Jinong ;
Buzin, Carolyn H. ;
Liu, Qiang ;
Weiss, Lawrence ;
Kernstine, Kemp ;
Somlo, George ;
Sommer, Steve S. .
PLOS ONE, 2009, 4 (09)